Ono Pharmaceutical Co., Ltd. announced the opening of a new 733-square-meter office in Zug, Switzerland, to accommodate the company’s growth in Europe and partner markets. The occasion will be commemorated with a ceremony attended by company management, including the CEO of Ono, Gyo Sagara, President and CEO of Deciphera, Ryota Udagawa, and regional government officials, including Director of Economic Affairs of Kanton Zug, Silvia Thalmann-Gut.

“The opening of our new Zug office marks a key milestone in Deciphera’s journey. Following the Ono acquisition, we have significantly broadened our pipeline with several promising clinical candidates that have the potential to expand our commercial portfolio in the coming years. This office positions us for growth in international markets as we advance these candidates toward commercialization,” said Ryota Udagawa, President and Chief Executive Officer of Deciphera. “The Zug office plays a pivotal role as our hub in Europe, reinforcing our global footprint and enhancing our ability to better serve communities worldwide. Furthermore, our Zug office was recognized as the Best Workplace™ in Switzerland in its category in 2025 by Great Place to Work and we believe this new office will further contribute to attract and retain top talent as well as foster teamwork and collaboration.”

“I am always very pleased to see companies like Deciphera choose Zug as their International Hub and seeing the current expansion of office is a true testament to the incredible biotech and pharma eco-system that was developed over the years and that we will continue to support in the future," said Silvia Thalmann-Gut, Director of Economic Affairs of Kanton Zug.

Deciphera’s international office was founded in Zug in early 2021 and has since expanded across Europe.